N-SIDE, provider of innovative software and strategic consulting services, is pleased to announce the growing collaboration with Galapagos NV, biotechnology company. Galapagos has signed a contract to use the N-SIDE Suite for Clinical Trials (specifically the N-SIDE Supply and Dashboard Apps). By combining this innovative SaaS solution and N-SIDE consulting services, they will optimize clinical trial […]
read moreTake the guesswork out of clinical trial supply overage
Clinical trial supply management is challenging – ensuring there is no risk to patients receiving the right medication on-time with highly unpredictable demand. Due to the nature of randomized clinical trials, there is inherent uncertainty in patient demand. Buffer stock, often referred to as clinical trial supply overage, is required to be sure that the right […]
read moreJoin us at Clinical Trial Supply Chain Strategy Meeting Europe 2019!
Join Sébastien Coppe, Director Life Sciences, at the Clinical Trial Supply Chain Strategy Meeting Europe in Zurich on October 10th. Sébastien will lead a roundtable discussion on “Real-time monitoring of the single source of truth for your end-to-end clinical supply chain” Participants will learn about how to: Build and share your single source of truth with […]
read moreWebinar : Clinical supplies forecasting with a single source of truth
“How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth” Our webinar at a glance: A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication can […]
read moreN-SIDE welcomes Wade Wirta as US Managing Director
N-SIDE is pleased to welcome Wade Wirta as N-SIDE US Managing Director. Wade has over 25 years of experience working in the pharmaceutical industry, with an extensive background in clinical trial supply and optimization. In his new role, Wade will be developing the US market for N-SIDE and accelerating the growth of our new N-SIDE […]
read moreAstraZeneca selects N-SIDE Suite for Clinical Trials to optimize and monitor clinical trial supply chain
N-SIDE announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement , AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain. “N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across […]
read more